Theravance Biopharma (TBPH) Interest & Investment Income (2014 - 2025)
Theravance Biopharma's (TBPH) quarterly Interest & Investment Income came in at $42000.0 in Q3 2025, down 41.67% year-on-year from $72000.0 in Q3 2024, and up 520.0% on a QoQ basis from -$10000.0 in Q2 2025.
Theravance Biopharma (TBPH) Interest & Investment Income (2014 - 2025) Analysis & Trends
Theravance Biopharma (TBPH) has 12 years of Interest & Investment Income data on file, last reported at $42000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Theravance Biopharma | 864.82 Mn | 470.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 42,000.00 |
| Jun 30, 2025 | -10,000.00 |
| Mar 31, 2025 | -7,000.00 |
| Sep 30, 2024 | 72,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Mar 31, 2024 | 24,000.00 |
| Sep 30, 2023 | 61,000.00 |
| Jun 30, 2023 | -337,000.00 |
| Mar 31, 2023 | 66,000.00 |
| Sep 30, 2022 | -76,000.00 |
| Jun 30, 2022 | -17,000.00 |
| Mar 31, 2022 | -28,000.00 |
| Sep 30, 2021 | 6,000.00 |
| Jun 30, 2021 | -9,000.00 |
| Mar 31, 2021 | -30,000.00 |
| Sep 30, 2020 | -158,000.00 |
| Jun 30, 2020 | -232,000.00 |
| Mar 31, 2020 | 367,000.00 |
| Sep 30, 2019 | -35,000.00 |
| Jun 30, 2019 | 165,000.00 |